Cite
HARVARD Citation
Krekeler, G. et al. (n.d.). 3221 Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice. European journal of cancer. pp. S656-. [Online].